Clin2
NCT07052409Likely a fitEnrolling by invitation

Protecting HIV-exposed infants from severe infections

Gut Microbiome

Part of Immune system & allergy, Infections clinical trials.

This trial studies ways to protect babies who were exposed to HIV before birth but are not infected themselves. It aims to find better interventions to prevent severe infections in these infants.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
72 people
Ages
6 months to 45 years
Study type
Interventional

Who can take part

  • You are pregnant and have HIV.
  • Your baby will be exposed to HIV but not infected.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06613789Not yet recruiting· Phase 1
HIV vaccine study for babies born to mothers with HIV

This trial tests an experimental vaccine for babies who were exposed to HIV while in the womb but are not infected. Mothers must be living with HIV, on treatment, and deliver by C-section at the study hospital in Soweto.

Soweto, Gauteng
NCT05923333Recruiting
Breastfed infants of HIV-exposed mothers get a probiotic

This study gives a specific probiotic (from B. infantis) to babies born without HIV to see if it can improve the baby’s early immune health. It focuses on babies who are HIV-exposed because their mother has HIV and plans to exclusively breastfeed for the first 6 months.

Cape Town
NCT02140255Recruiting· Phase 1/Phase 2
Intensive early HIV treatment in newborns to aim for remission

This study gives very early, intensive HIV medicine to infants diagnosed with HIV and follows them closely to see if HIV can go into remission (stop being detectable without ongoing treatment). It may help families understand whether treating right after birth can change a child’s long-term HIV outlook.

La Jolla, California
NCT06517693Recruiting· Phase 1
HIV antibody safety study for newborns at risk

This study tests whether giving a combination of two lab-made antibodies (PGT121.414.LS and VRC07-523LS) to newborns exposed to HIV during pregnancy is safe and how the body processes them. It may help protect infants from getting HIV after birth.

Los Angeles, California
NCT06267508Recruiting
HIV testing and treatment for newborns

This study looks at ways to test and treat newborns for HIV early to improve their long-term health. It is for mothers with HIV whose babies are less than 3 days old and who are willing to have their babies tested and followed at home.

Beira
NCT07655128Not yet recruiting· Phase 1/Phase 2
Early antibodies for infants with HIV

This study tests whether giving a special antibody treatment to babies living with HIV, shortly after birth, can help their immune system fight the virus better. It aims to improve their long-term health.

Hear when a new Gut Microbiome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.